NASDAQ:AMTI
Delisted
Applied Molecular Transport Inc. Stock News
$0.263
+0 (+0%)
At Close: Mar 25, 2024
Applied Molecular Transport Stock Price Increased Over 25% Intraday: Why It Happened
10:36am, Thursday, 01'st Apr 2021
The stock price of Applied Molecular Transport (NASDAQ: AMTI) increased by over 25% during intraday trading. This is why it happened.
Applied Molecular Transport Announces Pricing of Public Offering of Common Stock
08:45pm, Wednesday, 31'st Mar 2021
SOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the pricing of an und
Applied Molecular Transport Announces Proposed Public Offering of Common Stock
04:11pm, Monday, 29'th Mar 2021
SOUTH SAN FRANCISCO, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that it has commenced
Applied Molecular Transport Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
04:05pm, Friday, 19'th Mar 2021
Successfully initiated four planned Phase 2 trials for oral AMT-101 with enrollment ongoing
3 Biotech Stocks That Have Already Rocketed Higher in 2021
06:56am, Saturday, 13'th Mar 2021
Here's why these highfliers could have more fuel in the tank.
Applied Molecular Transport to Present at Oppenheimer 31st Annual Healthcare Conference
08:00am, Tuesday, 09'th Mar 2021
SOUTH SAN FRANCISCO, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, P
Applied Molecular Transport Expands Clinical Pipeline and Announces First Subject Dosed in Phase 1a Trial of Oral AMT-126
08:00am, Monday, 01'st Mar 2021
Company expands pipeline with second clinical program, AMT-126, an oral IL-22 fusion biologic therapy for diseases associated with intestinal epithelial barrier defects
Applied Molecular Transport Reports Second Quarter 2020 Financial Results
08:00pm, Tuesday, 11'th Aug 2020
-Company debuts with successful $177 million IPO -Plans to initiate three Phase 2 clinical trials for AMT-101 in 2020; anticipates top-line data readouts in 2H 2021 and 1H 2022 -On track to file
Applied Molecular Transport Named as One of Three Finalists for the Fierce Innovations Awards for AMT-101
12:00pm, Wednesday, 05'th Aug 2020
AMT-101, an oral gastrointestinal-selective rhIL-10 agonist that has been designed for active transport across the intestinal epithelium, has demonstrated encouraging results in a Phase 1b clinical tr
Stocks To Watch: Fireworks For Nikola, Tesla And Micron
09:00am, Saturday, 27'th Jun 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO
12:13pm, Tuesday, 16'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) * Applied Molecular Transport Inc (NASDAQ: AMTI) (wen
SOUTH SAN FRANCISCO, Calif., June 09, 2020 -- Applied Molecular Transport (Nasdaq: AMTI), a clinical-stage biopharmaceutical company, today announced the closing of its initial.
Applied Molecular Transport Announces Pricing of Initial Public Offering
02:40am, Friday, 05'th Jun 2020
All of the shares of common stock are being offered by AMT. The shares are expected to begin trading on the Nasdaq Global Select Market on June 5, 2020, under the ticker symbol “AMTI.” In additi
